Teijin Nakashima Doubles Down On Spine And Trauma In Japan
In a deal with Otsuka, Teijin has agreed to acquire KiSCO’s spine and trauma operations, commencing February 2021.
You may also be interested in...
Japan's Teijin is adding a family of bioresorbable, osteosynthetic bone-fixation devices to its modest but growing orthopedics portfolio.
Minute Insight: MeMed Announces Viral/Bacterial Infection Differentiation Results, Commercial Partnership
DiaSorin will distribute MeMed BV, a rapid point-of-care test that can differentiate bacterial and viral infections, under a new commercial agreement.
Xeltis, a Netherlands-based company producing cardiovascular implants to stimulate natural regeneration of biological tissue, has received funding from the European Union’s rescue fund.